A Triple Disaster Phenomenon For the Coronary Artery An Impressive Case of No-reflow and Complication Management

  • Emirhan Çakır Cardiology Department of Edirne Sultan 1. Murat State Hospital, Edirne, Turkey
  • Çağlar Kaya Cardiology Department of Trakya University, Edirne, Turkey https://orcid.org/0000-0002-2968-5352
  • Kenan Yalta Cardiology Department of Trakya University, Edirne, Turkey https://orcid.org/0000-0001-5966-2488
Keywords: Acute Coronary Syndrome, Adrenaline, No-reflow, Stent Balloon Rupture

Abstract

Background: Coronary no-reflow is characterized by very slow or absent epicardial blood flow. It results in inadequate myocardial perfusion and is an independent predictor of mortality due to malignant arrhythmias and heart failure.

Case Illustration: This case describes a patient who underwent angiography due to a reperfused inferior myocardial infarction. Following the diagnostic procedure, a decision was made to perform a primary percutaneous intervention on the Circumflex (Cx) artery. When the stent balloon was inflated to the optimal pressure, it burst. The control image revealed the development of no-reflow after the Left Main Coronary Artery (LMCA). This potentially fatal condition was successfully treated with the administration of Intracoronary (IC) adrenaline.

Conclusion: No-reflow is a significant factor affecting mortality. The occurrence of this phenomenon in multiple vessels further increases this risk, but it can be effectively managed with IC adrenaline, and multiple-vessel no-reflow can be treated.

Downloads

Download data is not yet available.

References

1. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008;117(24):3152-56.
2. Tasar O, Karabay AK, Oduncu V, Kirma C. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2019;30:270-6.
3. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54:281-92.
4. Simpfendorfer CC, Dimas AP, Zaidi A, Hollman J, Franco I, Knezinek V, Hobbs RE. Balloon rupture during coronary angioplasty. Angiology. 1986;37:828-31.
5. Ramjane K, Han L, Jin C. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol. 2008;13(3):121-8.
6. Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis. Indian Heart J. 2018;70(3):406-18.
7. Sofidis G , Kartas A , Karagiannidis E , Stalikas N , Sianos G. A Case of Balloon Rupture During Coronary Angioplasty: Slow Flow Requiring Swift Action. Cureus. 2020;12(7):e9335.
8. Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017;10:215-23.
9. Simoni L, Gjana A, Ziu K, Dibra A, Goda A. Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention. Cureus. 2024;16(5):e60338.
10. Zhang ZP, Su X, Yang YC, Wu MX, Liu B, Liu CW. Cardiac arrest with coronary artery spasm: does the use of epinephrine during cardiopulmonary arrest exacerbate the spasm? Am J Emerg Med. 2015;33(3):479.
Published
2026-09-08
Views & Downloads
Abstract views: 46   
PDF downloads: 33   
How to Cite
Çakır, E., Kaya, Çağlar, & Yalta, K. (2026). A Triple Disaster Phenomenon For the Coronary Artery An Impressive Case of No-reflow and Complication Management. Indonesian Journal of Cardiology. https://doi.org/10.30701/ijc.1823
Section
Case Reports